Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Junichiro Miyazaki"'
Autor:
Junichiro Miyazaki, Keiichi Ito, Tomonobu Fujita, Yuriko Matsuzaki, Takako Asano, Masamichi Hayakawa, Tomohiko Asano, Yutaka Kawakami
Publikováno v:
Translational Oncology, Vol 10, Iss 2, Pp 142-152 (2017)
Renal cell carcinoma (RCC) is the most lethal urological malignancy with high risk of recurrence; thus, new prognostic biomarkers are needed. In this study, a new RCC antigen, PTPL1 associated RhoGAP1 (PARG1), was identified by using serological iden
Externí odkaz:
https://doaj.org/article/6822cf628b284de0bb7cac360e4ee86e
Autor:
Yutaka Kawakami, Yuriko Matsuzaki, Tomonobu Fujita, Junichiro Miyazaki, Takako Asano, Tomohiko Asano, Keiichi Ito, Masamichi Hayakawa
Publikováno v:
Translational Oncology, Vol 10, Iss 2, Pp 142-152 (2017)
Renal cell carcinoma (RCC) is the most lethal urological malignancy with high risk of recurrence; thus, new prognostic biomarkers are needed. In this study, a new RCC antigen, PTPL1 associated RhoGAP1 (PARG1), was identified by using serological iden
Autor:
Junichiro Miyazaki, Sunthamala Nuchsupha, Ryosuke Satomi, Kenta Nakamura, Shinobu Noji, Taeko Hayakawa, Hajime Kamijuku, Kinya Tsubota, Tomonari Kinoshita, Nobuo Tsukamoto, Toshiharu Sakurai, Hiroshi Nishio, Tomonori Yaguchi, Naoshi Kawamura, Yutaka Kawakami, Juri Sugiyama, Haruna Nagumo, Ikumi Katano, Boryana Popivanova, Tomonobu Fujita, Chie Kudo-Saito
Publikováno v:
Immunotherapy of Cancer ISBN: 9784431550303
Cancer immunotherapies utilizing tumor-specific T-cell responses, immune-checkpoint blockade, and T-cell-based adoptive cell therapy, have recently shown durable responses in advanced patients with various cancers. However, there are still cancer typ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ef52d4f2072799124265b06187c1c60
https://doi.org/10.1007/978-4-431-55031-0_24
https://doi.org/10.1007/978-4-431-55031-0_24
Autor:
Masakazu Ueda, Takashi Iwata, Nobuo Tsukamoto, Hirotoshi Hasegawa, Koji Okabayashi, Tomonobu Fujita, Nobumaru Hirao, Yutaka Kawakami, Junichiro Miyazaki, Shinobu Noji, Hiroya Takeuchi, Yuko Kitagawa, Tsutomu Okada, Naoki Goshima
Publikováno v:
Cancer Sci
Esophageal squamous cell cancer (ESCC) is one of the most common lethal tumors in the world, and development of new diagnostic and therapeutic methods is needed. In this study, cancer‐testis antigen, BORIS, was isolated by functional cDNA expressio
Autor:
Naoshi Kawamura, Tomonari Kinoshita, Toshiharu Sakurai, Kenta Nakamura, Kinya Tsubota, Hajime Kamijuku, Tomonori Yaguchi, Tracy Hsin-ju Liu, Sunthamala Nuchsupha, Hiroshi Nishio, Ryosuke Satomi, Nobuo Tsukamoto, Juri Sugiyama, Yutaka Kawakami, Gaku Ohmura, Boryana Popivanova, Junichiro Miyazaki, Taeko Hayakawa, Tomonobu Fujita, Chie Kudo-Saito, Li Qian
Publikováno v:
Resistance to Targeted Anti-Cancer Therapeutics ISBN: 9783319178066
Although cancer immunotherapy has recently demonstrated durable responses even in patients with advanced cancer, not all patients or cancer types respond to the therapy. Pretreatment immune status varies among cancer patients and is correlated with r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf2f2cc904831a4e7628191929384f3c
https://doi.org/10.1007/978-3-319-17807-3_13
https://doi.org/10.1007/978-3-319-17807-3_13
Autor:
Hiroshi Nishio, Haruna Nagumo, Junichiro Miyazaki, Hajime Kamijuku, Tomonori Yaguchi, Tomonobu Fujita, Yutaka Kawakami, Toshiharu Sakurai, Tracy Hsin-ju Liu, Sunthamala Nuchsupha, Li Qian, Ryosuke Satomi, Kinya Tsubota, Naoshi Kawamura, Nobuo Tsukamoto, Chie Kudo-Saito, Taeko Hayakawa, Tomonari Kinoshita, Boryana Popivanova, Kenta Nakamua, Gaku Ohmura, Juri Sugiyama
Publikováno v:
Inflammation and Immunity in Cancer ISBN: 9784431553267
Cancer immunotherapies, particularly immune-checkpoint blockade and T cell-based adoptive cell therapy, have recently been recognized as cancer treatments that show strong and durable responses even for advanced cancer patients with multiple metastas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43ac882dd444b3b10cf9642b049b31e2
https://doi.org/10.1007/978-4-431-55327-4_20
https://doi.org/10.1007/978-4-431-55327-4_20
Autor:
Boryana Popivanova, Hidetoshi Sumimoto, Jeong Hoon Park, Junichiro Miyazaki, Naoshi Kawamura, Shoko Nakamura, Tomoko Iwata-Kajihara, Takahiro Tsujikawa, Chie Kudo-Saito, Tomonori Yaguchi, Yutaka Kawakami
Publikováno v:
Frontiers in Oncology, Vol 3 (2013)
Frontiers in Oncology
Frontiers in Oncology
In human cancer cells, a constitutive activation of MAPK, STAT3, β-catenin, and various other signaling pathways triggers multiple immunosuppressive cascades. These cascades result in the production of immunosuppressive molecules (e.g., TGF-β, IL-1
Autor:
Junichiro Miyazaki, Nobuo Tsukamoto, Yutaka Kawakami, Hideyuki Saya, Eri Takahashi, Kazuo Tsubota, Takatsugu Ishimoto, Hiroshi Mochimaru, Susumu Ishida, Takashi Koto, Hidenobu Tanihara, Kousuke Noda, Yoko Ozawa, Tomonori Yaguchi, Toshihide Kurihara
Publikováno v:
Investigative ophthalmologyvisual science. 50(9)
Purpose CD44 is a cell-surface adhesion molecule and receptor for hyaluronan (HA), one of the major extracellular matrix components. The purpose of the present study was to clarify a role of HA and CD44 in the development of choroidal neovascularizat
Autor:
Makoto Sumitomo, Yuriko Matsuzaki, Akio Horiguchi, Tomohiko Asano, Tomonobu Fujita, Masamichi Hayakawa, Keiichi Ito, Junichiro Miyazaki, Takako Asano, Yutaka Kawakami, Hidehiko Yoshii, Masaru Murai
Publikováno v:
Journal of Urology. 181:107-107